ArticleOncotarget2015

Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.

Rayan S Moussa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.